Health

Datasea Inc. Issues Statement Regarding Recent Market Activity

BEIJING, Nov. 18, 2025 /PRNewswire/ -- Datasea Inc. (NASDAQ: DTSS) ("Datasea" or the "Company") ,aNevada-based high-tech enterprise engaged in acoustic technologies and AI multimodal digitalization, today issues a brief statement regarding recent trading activity in its common stock. The Company...

2025-11-18 22:30 2425

Feelingirl FeelCare™ Collection Wins American Good Design Award for Merging Medical Precision with Everyday Elegance

LOS ANGELES, Nov. 18, 2025 /PRNewswire/ -- Feelingirl, a brand redefining shapewear through comfort and confidence, announced that its FeelCare™ Collection, designed specifically for women recovering from surgery, has been honored with the prestigious American Good Design Award for its seamless ...

2025-11-18 22:00 961

Kangpu to Present Latest Study Results of epaldeudomide (KPG-818) at the 67th ASH Annual Meeting

HEFEI, China, Nov. 18, 2025 /PRNewswire/ -- Kangpu Biopharmaceuticals announced today that the company will deliver a poster presentation to highlight the Phase I clinical trial results of epaldeudomide (KPG-818) for the treatment of hematological malignancies at the 67th American Society of Hema...

2025-11-18 21:00 977

Taiwan's CMUH Completes HIMSS "Grand Slam," Achieving DIAM Stage 7 Certification

TAICHUNG, Nov. 17, 2025 /PRNewswire/ -- China Medical University Hospital (CMUH) has secured one of the world's highest honors in digital health, becoming the first hospital inTaiwan to achieve Stage 7 certification under the HIMSS Digital Imaging Adoption Model (DIAM). The designation, awarded b...

2025-11-18 09:01 973

Bambusa Therapeutics Announces Completion of Series A-2 Financing to Accelerate Next-Generation Bispecific Programs

BOSTON, Nov. 17, 2025 /PRNewswire/ -- Bambusa Therapeutics, Inc. ("Bambusa"), a clinical-stage biotechnology company pioneering next-generation bispecific antibodies for immunology and inflammation (I&I), today announced the completion of its oversubscribed Series A-2 financing, closed at a subst...

2025-11-17 22:15 1085

AKA Foods Secures 17.2 Million Dollars in Seed Funding to launch the world's first secure AI system for food innovation

New AKA Studio consolidates organisational knowledge, incorporates sensory evaluation, and applies AI assistants to guide formulation and optimisation AMSTELVEEN, Netherlands, Nov. 17, 2025 /PRNewswire/ -- AKA Foods Ltd . today announced the completion of a 17.2 million ...

2025-11-17 17:00 998

Cardiovalve Submits CE File for Approval Following Successful TARGET Study Completion

Exciting Data on Cardiovalve Tricuspid Valve Replacement Device Presented at PCR London Valves 2025 meeting. LONDON, Nov. 17, 2025 /PRNewswire/ -- Venus Medtech (Hangzhou) Inc. (2500.HK) today announced that Cardiovalve has submitted the CE technical file for its transcatheter tricuspid valve re...

2025-11-17 17:00 861

Akeso's Bispecific Antibody Targeting Aβ and BBB-Expressed Receptor Approved for Alzheimer's Disease Clinical Trials in China

HONG KONG, Nov. 16, 2025 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926.HK) announced that its AK152, a novel bispecific antibody targeting both amyloid-beta (Aβ) and blood-brain barrier (BBB) expressed receptor, has been granted approval by the National Medical Products Administration (NMPA) to initiat...

2025-11-17 10:29 1639

MATELASER Launches W1 REGEN Series -- The World's Lightest Wearable Medical-Grade Cold Laser for Deep Tissue Healing

MIAMI, Fla., Nov. 14, 2025 /PRNewswire/ -- MATELASER, INC., an FDA-certified U.S. manufacturer of therapeutic laser systems, today announced the crowdfunding debut of its W1 REGEN Series, including W1 REGEN and W1 REGEN ULTRA. Weighing only 24 grams per module, the W1 REGEN is the world's lightes...

2025-11-15 00:00 2919

PRISM BioLab Achieved Initial Milestone and Receives the Milestone Payment in Drug Discovery Collaboration with Ono Pharmaceutical Co., Ltd.

TOKYO, Nov. 14, 2025 /PRNewswire/ -- PRISM BioLab, Co. Ltd. ("PRISM") announces that today, PRISM and Ono Pharmaceutical Co., Ltd. (Headquarters:Osaka; President and COO:Toichi Takino; hereinafter "Ono") have achieved the initial milestone in the drug discovery collaboration and PRISM has confirm...

2025-11-14 16:00 1155

Smartee Demonstrates World-Class Manufacturing Capacity to Support Global Growth

SHANGHAI, Nov. 14, 2025 /PRNewswire/ -- Smartee Denti-Technology has showcased its world-class production system, designed to meet the increasing demand for its clear aligner products across the globe. With cutting-edge technology and robust manufacturing capabilities, Smartee supports its global...

2025-11-14 14:44 1089

Shangpu Group Issues Authoritative Market Position Statement Recognizing Konjac Brother as the Pioneer of Xi'an Konjac Cold Noodles

BEIJING, Nov. 14, 2025 /PRNewswire/ -- Healthy food products grown in the konjac fields of Ankang,China, are gaining traction among international consumers, driven by Konjac Brother, a fast-growing Chinese food company committed to product innovation and health-focused foods. In a recent develop...

2025-11-14 14:00 792

Zhang Xinyuan Hosts Two Vimi Wellness Ambassador Advancement Contests Within a Year, Attracting Over 3,000 Chinese Women

BOAO, China, Nov. 13, 2025 /PRNewswire/ -- The "Vimi Wellness Ambassador Advancement Contest," hosted by Ms. Zhang Xinyuan, a well-known Chinese gender relationship expert and founder of the Vimi Wellness brand, was successfully held inHainan, China, in June and October 2025. The series of contes...

2025-11-14 09:26 1052

Datasea Reports First Quarter Gross Profit of $1.2 Million, a 4.9x Increase Year-Over-Year in its Strategy to Achieve High-Tech Product Profitability

Gross Margin Rose to 8.5% through High-Tech Products Mix and Cost Efficiencies BEIJING, Nov. 13, 2025 /PRNewswire/ -- Datasea Inc. (Nasdaq: DTSS) ("Datasea" or the "Company"), aNevada-based high-tech enterprise engaged in acoustic technologies and AI multimodal digitalization, today announces its...

2025-11-13 22:31 3794

LISCure Expands Global Partnerships for BBB Shuttle Platform 'ExoPN-101'; Signs Fourth MTA with Leading Pharma Partner

SEOUL, South Korea, Nov. 13, 2025 /PRNewswire/ -- LISCure Biosciences ("LISCure"), a biotechnology company advancing next-generation therapeutics, today announced that it has entered into a new Material Transfer Agreement (MTA) with a leading global pharmaceutical company for its proprietary blo...

2025-11-13 21:00 1061

Medical AI Company VUNO Reports Profit in Q3, Driven by DeepCARS Growth

- 11 Consecutive Quarters of Revenue Growth; Q3 Revenue Exceeds KRW 10 billion for the First Time SEOUL, South Korea, Nov. 12, 2025 /PRNewswire/ -- VUNO Inc., a global medical AI company, announced that it was profitable in the third quarter of 2025, recording consolidated revenue ofKRW 10.8 bil...

2025-11-13 09:47 1100

Medit and OraQ Announce Strategic Partnership to Advance AI-Driven Intelligence in Digital Dentistry

Collaboration unites two leaders in innovation to redefine how clinical insight is delivered across the dental ecosystem NEWPORT BEACH, Calif., Nov. 12, 2025 /PRNewswire/ -- Medit, a global leader in 3D intraoral scanning solutions, and OraQ, a pioneer in AI-powered clinical intelligence, today ...

2025-11-12 21:00 1268

EirGenix Signed The Commercial Licensing Agreement for Its Second HER2 Biosimilar Asset EG1206A

TAIPEI, Nov. 12, 2025 /PRNewswire/ -- EirGenix Inc.(TWSE: 6589) today announced that it has entered into a second global exclusive licensing agreement with international biosimilar leader Sandoz AG (SIX:SDZ/OTCQX:SDZNY) for the commercialization of its independently developed breast cancer biosim...

2025-11-12 20:47 1477

CureGene Unveils Groundbreaking Preclinical Data for CG-0416, a Novel Oral Non-GLP-1 Therapy, at Obesity Week 2025

CG-0416, a highly liver-targeted THR-β agonist, demonstrates high-quality weight loss by reducing fat mass while preserving muscle, both as a monotherapy and in combination withGLP-1 RAs. ATLANTA, Nov. 11, 2025 /PRNewswire/ -- CureGene Pharmaceuticals ("CureGene") today announced the first discl...

2025-11-12 06:24 2099

Strategic Partnership Between Sanyou Bio and Yugong Bio to Accelerate Expansion in High-End Synthetic Enzyme Market

SHANGHAI, Nov. 11, 2025 /PRNewswire/ -- Sanyou Bio and Yugong Bio today announced the signing of a strategic cooperation agreement. This powerful alliance marks a significant step to deepen their collaboration in the development of high-end synthetic molecular enzymes. This collaboration is base...

2025-11-11 22:00 1645
1 ... 14151617181920 ... 317